164 related articles for article (PubMed ID: 9433335)
1. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic.
Maj M; Pirozzi R; Magliano L; Bartoli L
Am J Psychiatry; 1998 Jan; 155(1):30-5. PubMed ID: 9433335
[TBL] [Abstract][Full Text] [Related]
2. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study.
Strober M; Morrell W; Lampert C; Burroughs J
Am J Psychiatry; 1990 Apr; 147(4):457-61. PubMed ID: 2107763
[TBL] [Abstract][Full Text] [Related]
3. Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors.
Maj M; Pirozzi R; Magliano L
Am J Psychiatry; 1995 Dec; 152(12):1810-1. PubMed ID: 8526252
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of "switching" in patients with bipolar disorder: a 10-year prospective follow-up study.
Maj M; Pirozzi R; Magliano L; Bartoli L
Am J Psychiatry; 2002 Oct; 159(10):1711-7. PubMed ID: 12359677
[TBL] [Abstract][Full Text] [Related]
5. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
Simhandl C; König B; Amann BL
J Clin Psychiatry; 2014 Mar; 75(3):254-62; quiz 263. PubMed ID: 24717379
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of patients with bipolar disorder commenced on lithium prophylaxis during hospitalization: a complete 15-year register-based follow-up.
Licht RW; Vestergaard P; Brodersen A
Bipolar Disord; 2008 Feb; 10(1):79-86. PubMed ID: 18199244
[TBL] [Abstract][Full Text] [Related]
7. Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: results of the MAP study.
Kleindienst N; Greil W
Neuropsychobiology; 2000; 42 Suppl 1():2-10. PubMed ID: 11093063
[TBL] [Abstract][Full Text] [Related]
8. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder.
Calabrese JR; Shelton MD; Rapport DJ; Youngstrom EA; Jackson K; Bilali S; Ganocy SJ; Findling RL
Am J Psychiatry; 2005 Nov; 162(11):2152-61. PubMed ID: 16263857
[TBL] [Abstract][Full Text] [Related]
9. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder.
Waters B; Lapierre Y; Gagnon A; Cahudhry R; Tremblay A; Sarantidis D; Gray R
Biol Psychiatry; 1982 Nov; 17(11):1323-9. PubMed ID: 6817830
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder.
Maj M; Arena F; Lovero N; Pirozzi R; Kemali D
Pharmacopsychiatry; 1985 Sep; 18(5):309-13. PubMed ID: 3931108
[TBL] [Abstract][Full Text] [Related]
11. Lithium prophylaxis in recurrent affective illness.
Prien RF; Klett CJ; Caffey EM
Am J Psychiatry; 1974 Feb; 131(2):198-203. PubMed ID: 4587809
[No Abstract] [Full Text] [Related]
12. Long-term outcome of lithium prophylaxis in bipolar disorder with mood-incongruent psychotic features: a prospective study.
Maj M; Pirozzi R; Bartoli L; Magliano L
J Affect Disord; 2002 Sep; 71(1-3):195-8. PubMed ID: 12167516
[TBL] [Abstract][Full Text] [Related]
13. Is there a loss of efficacy of lithium in patients treated for over 20 years?
Berghöfer A; Müller-Oerlinghausen B
Neuropsychobiology; 2000; 42 Suppl 1():46-9. PubMed ID: 11093072
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of lithium prophylaxis in patients initially classified as complete responders.
Maj M; Pirozzi R; Kemali D
Psychopharmacology (Berl); 1989; 98(4):535-8. PubMed ID: 2505295
[TBL] [Abstract][Full Text] [Related]
15. Lithium discontinuation and subsequent effectiveness.
Coryell W; Solomon D; Leon AC; Akiskal HS; Keller MB; Scheftner WA; Mueller T
Am J Psychiatry; 1998 Jul; 155(7):895-8. PubMed ID: 9659853
[TBL] [Abstract][Full Text] [Related]
16. Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.
Pfennig A; Schlattmann P; Alda M; Grof P; Glenn T; Müller-Oerlinghausen B; Suwalska A; Rybakowski J; Willich SN; Bauer M; Berghöfer A
Bipolar Disord; 2010 Jun; 12(4):390-6. PubMed ID: 20636636
[TBL] [Abstract][Full Text] [Related]
17. The long term prophylaxis of affective disorders.
Koukopoulos A; Reginaldi D; Minnai G; Serra G; Pani L; Johnson FN
Adv Biochem Psychopharmacol; 1995; 49():127-47. PubMed ID: 7653332
[No Abstract] [Full Text] [Related]
18. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J;
Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317
[TBL] [Abstract][Full Text] [Related]
19. Depression as a lethal disease: prevention strategies.
Coppen A
J Clin Psychiatry; 1994 Apr; 55 Suppl():37-45. PubMed ID: 8077174
[TBL] [Abstract][Full Text] [Related]
20. Mortality in 497 patients with affective disorders attending a lithium clinic or after having left it.
Kallner G; Lindelius R; Petterson U; Stockman O; Tham A
Pharmacopsychiatry; 2000 Jan; 33(1):8-13. PubMed ID: 10721878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
